Nasus Pharma Ltd
NSRX- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002029039
No open-market purchases or sales by Nasus Pharma Ltd insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $7.53M in total; no superinvestor holds it.
Superinvestors holding NSRX, Q2 2026
No superinvestor reported holding NSRX in Q2 2026.